Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus
    19.
    发明授权
    Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus 失效
    具有1,4-二氧代C,N-末端的抗原肽衍生物

    公开(公告)号:US5484771A

    公开(公告)日:1996-01-16

    申请号:US219600

    申请日:1994-03-29

    摘要: Described herein are peptide derivatives of the formula R.sup.1 NH--CO--Q--C(O)--NR.sup.2 --CH[CH.sub.2 C(O)--Y]--C(O)--NH--CH[CR.sup.3 (R.sup.4)--COOH]--C(W)--NH--CHR.sup.5 --Z wherein R.sup.1 is an optionally substituted alkyl or optionally substituted phenylalkyl, R.sup.2 is hydrogen or alkyl, R.sup.3 and R.sup.4 each independently is hydrogen or alkyl, or R.sup.3 and R.sup.4 are joined to form a cycloalkyl. R.sup.5 is alkyl, cycloalkyl or (cycloalkyl)alkyl, Q is a divalent radical, for example, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH-- or 1,2-cyclohexanediyl, which serves as a two carbon spacer. W is oxo or thioxo, Y is, for example, an alkoxy or a monosubstituted or disubsdtuted ammo, and Z is a terminal unit, for example, hydrogen, COOH or CH.sub.2 OH. The derivatives are useful for treating herpes infections.

    摘要翻译: 本文描述的是式R1NH-CO-QC(O)-NR2-CH [CH2C(O)-Y] -C(O)-NH-CH [CR3(R4)-COOH] -C(W)的肽衍生物 -NH-CHR 5 -Z,其中R 1是任选取代的烷基或任选取代的苯基烷基,R 2是氢或烷基,R 3和R 4各自独立地是氢或烷基,或者R 3和R 4连接形成环烷基。 R 5是烷基,环烷基或(环烷基)烷基,Q是二价基团,例如-CH 2 CH 2 - , - CH = CH-或1,2-环己二基,其用作二碳间隔基。 W是氧代或硫代,Y是例如烷氧基或单取代或未取代的氨基,Z是末端单元,例如氢,COOH或CH 2 OH。 该衍生物可用于治疗疱疹感染。